Hope Therapeutics Revenue
Mental Health Care • • 1-10 Employees
$
Hope Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Mental Health Care industry and current estimated revenues | $273,776 |
| Total funding | $7,800,000 |
Key Contact at Hope Therapeutics
Stephen Durand
Director of Florida Clinic Operations for HOPE Therapeutics
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 621112 |
| Keywords | Therapy, Healthcare, Depression, Mental Health, Psychotherapy, Medicine, Ptsd, Psychiatry, Clinic, Ketamine |
| Founded | 2024 |
| Employees | 1-10 |
About Hope Therapeutics
Hope Therapeutics leverages the most innovative neuroplastic therapies, like TMS, IV Ketamine, and SPRAVATO®, augmented with psychotherapy and psychiatry, to create a new gold standard for personalized mental health.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Germany
United Kingdom
Côte d'Ivoire
Canada
Frequently asked questions
Hope Therapeutics is located in XX.
Hope Therapeutics generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
Hope Therapeutics has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Hope Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
Hope Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Hope Therapeutics has raised a total of $7,800,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
